Class I - Dangerous
cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
💊
Prescription Drugs
💊 Drugs • 12,141 recalls
Class I - Dangerous
cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
Levoxyl (levothyroxine sodium) tablets, USP, 88 mcg, packaged in a) 100-count bottles (NDC 60793-853-01) and b) 1000-count bottles (NDC 60793-853-10), Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620
King Legacy, a wholly owned subsidiary of Pfizer
Class I - Dangerous
Subpotent Drug: The products were below specification for potency at the expiry stability point.
Class I - Dangerous
cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
Levoxyl (levothyroxine sodium) tablets, USP, 175 mcg, packaged in a) 100-count bottles (NDC 60793-859-01) and b) 1000-count bottles (NDC 60793-859-10), Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620
King Legacy, a wholly owned subsidiary of Pfizer
Class I - Dangerous
Subpotent Drug: The products were below specification for potency at the expiry stability point.
Class I - Dangerous
cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
Class I - Dangerous
cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
Class I - Dangerous
cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
Class I - Dangerous
cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
Levoxyl (levothyroxine sodium) tablets, USP, 25 mcg, packaged in a) 100-count bottles (NDC 60793-850-01) and b) 1000-count bottles (NDC 60793-850-10), Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620
King Legacy, a wholly owned subsidiary of Pfizer
Class I - Dangerous
Subpotent Drug: The products were below specification for potency at the expiry stability point.
Class I - Dangerous
cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
Class I - Dangerous
cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
Class I - Dangerous
cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
Levoxyl (levothyroxine sodium) tablets, USP, 112 mcg, packaged in a) 100-count bottles (NDC 60793-855-01) and b) 1000-count bottles (NDC 60793-855-10), Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620
King Legacy, a wholly owned subsidiary of Pfizer
Class I - Dangerous
Subpotent Drug: The products were below specification for potency at the expiry stability point.
Levoxyl (levothyroxine sodium) tablets, USP, 50 mcg, packaged in a) 100-count bottles (NDC 60793-851-01) and b) 1000-count bottles (NDC 60793-851-10), Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620
King Legacy, a wholly owned subsidiary of Pfizer
Class I - Dangerous
Subpotent Drug: The products were below specification for potency at the expiry stability point.
Class I - Dangerous
cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
Levoxyl (levothyroxine sodium) tablets, USP, 150 mcg, packaged in a) 100-count bottles (NDC 60793-858-01) and b) 1000-count bottles (NDC 60793-858-10), Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620
King Legacy, a wholly owned subsidiary of Pfizer
Class I - Dangerous
Subpotent Drug: The products were below specification for potency at the expiry stability point.
Levoxyl (levothyroxine sodium) tablets, USP, 200 mcg, packaged in a) 100-count bottles (NDC 60793-860-01) and b) 1000-count bottles (NDC 60793-860-10), Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620
King Legacy, a wholly owned subsidiary of Pfizer
Class I - Dangerous
Subpotent Drug: The products were below specification for potency at the expiry stability point.
Class I - Dangerous
cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
Class I - Dangerous
cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.